As of 2006, the 5-year relative survival rates for prostate, breast, bladder colorectal and lung cancer are 100 percent, 90 percent, 81 percent, 67 percent and 16 percent respectively, reports the National Institutes of Health (NIH). The overall relative 5-year survival rate for all types of cancer
Survival rates for cancer are affected by the stage, or progression of the cancer. All cancer survival rates are given according to the stage of the cancer, as well as the 5 year survival of patients, according to the American Cancer Society.
The overall five-year survival rate for people with non-Hodgkin lymphoma is 69 percent, according to the American Cancer Society. For people with stage I Hodgkin lymphoma, the five-year survival rate is more than 90 percent, while for people with stage IV Hodgkin lymphoma, it is 65 percent.
The survival rate for pancreatic cancer is approximately 62 percent for 6 months after diagnosis and 31 percent for one year after initial diagnosis, according to Cancer Treatment Centers of America. The rate decreases dramatically after one year, with a survival rate of 10 percent after two years.
The overall 5-year survival for those afflicted with liver cancer is 16 percent, according to the American Society of Clinical Oncology. Liver cancer kills approximately 23,000 people annually in the United States, as of 2015. Approximately 33,190 people are diagnosed with primary liver cancer each
Average five-year relative survival rates are 99 percent for local ductal carcinoma in the breast and 84 percent for regionalized disease that has spread to the lymph nodes, according to the Susan G. Komen Foundation. After cancer spreads to other parts of the body, five-year relative survival is 26
The five-year survival rate for ovarian cancer is around 45.6 percent as of 2015, according to the National Cancer Institute. Survival rates depend largely on the stage of the ovarian cancer on initial diagnosis. The earlier the diagnosis, the higher the rate of survival.
The combined five-year survival rate for all stages of prostate cancer is nearly 100 percent, according to the American Cancer Society. The 10-year relative survival rate is 99 percent, and the 15-year relative survival rate is 94 percent.
The survival rate for both types of lymphoma cancers is good once treatment begins, according to Medical News Today. Of the patients diagnosed with non-Hodgkin's lymphoma, two-thirds survived for five years. 85 percent of patients diagnosed with Hodgkin's lymphoma meet or exceed the five-year surviv
As of 2014, the 5-year survival rate of those afflicted with uterine cancer that has not metastasized to other areas of the body is 95 percent, according to Cancer.net. Around 52,630 women will be diagnosed with uterine cancer in 2014.